Found 15 matching trials
Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients NA The goal of this clinical trial is to compare responses to Varicella Zoster...
Show More Location
Royal Adelaide Hospital
Learn More & Join Trial
Vaccine Responses in Patients With B Cell Malignancies PHASE4 Background:
People with B cell malignancies (blood cancers) often cannot m...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I) PHASE2 Background:
People who have cancer tend to get sick more often. This is in...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above PHASE1 The purposes of the study are to evaluate the safety and tolerability of di...
Show More Status
Active Not Recruiting
Location
Yanjin District Center for Disease Control and Prevention
Learn More & Join Trial
A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 40 Years and Older PHASE2 This phase 2 study in China will evaluate the immunogenicity and safety of ...
Show More Status
Active Not Recruiting
Location
Hengnan County Center for Disease Control and Prevention
Learn More & Join Trial
Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older PHASE1 This phase 1 study in China will evaluate the safety and immunogenicity of ...
Show More Location
Guangdong Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Systems Biology of Zoster Vaccine PHASE2 The purpose of the study is to better understand how the immune system resp...
Show More Learn More & Join Trial
Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents EARLY_PHASE1 The purpose of this study is to measure the effect of the Shingrix vaccine ...
Show More Location
Fran and Earl Ziegler College of Nursing
Learn More & Join Trial
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population PHASE1 Background:
Shingles is a painful, blistering rash caused by the same viru...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Simultaneous RZV and aIIV4 Vaccination PHASE4 The overall aim of the study is to compare the safety of simultaneous Zoste...
Show More Location
Johns Hopkins University
Learn More & Join Trial